Allozyne Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

Allozyne General Information

Description

Provider of protein therapeutic product candidates for the treatment of autoimmune and inflammatory diseases and cancer. The company develops technologies that improve the efficacy, safety, dosing and other characteristics of protein-based therapeutics.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 999 Third Avenue
  • Suite 3400
  • Seattle, WA 98104
  • United States
Primary Industry
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 999 Third Avenue
  • Suite 3400
  • Seattle, WA 98104
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allozyne Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Jan-2014 Completed Generating Revenue
5. Later Stage VC (Series B2) 15-Aug-2013 Completed Generating Revenue
4. Later Stage VC (Series B2) 01-Jun-2012 Completed Generating Revenue
3. Merger/Acquisition 22-Dec-2011 Cancelled Generating Revenue
2. Early Stage VC (Series B) 31-Oct-2007 $33M $36.4M Completed Startup
1. Early Stage VC (Series A) 17-Nov-2005 $3.4M $3.4M Completed Startup
To view Allozyne’s complete valuation and funding history, request access »

Allozyne Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series A 6,801,499 $0.001000 $0.06 $1 $1 1x $1 14.07%
To view Allozyne’s complete cap table history, request access »

Allozyne Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of protein therapeutic product candidates for the treatment of autoimmune and inflammatory diseases and cancer.
Pharmaceuticals
Seattle, WA
11 As of 2016

Seattle, WA
 

Englewood, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Allozyne Competitors (6)

One of Allozyne’s 6 competitors is Kubota Vision, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kubota Vision Formerly VC-backed Seattle, WA
Ampio Pharmaceuticals Corporation Englewood, CO
Cardiff Oncology Formerly Angel backed San Diego, CA
Evonile Pharma Private Equity-Backed Mumbai, India
Summit Therapeutics Formerly VC-backed Miami, FL
To view Allozyne’s complete competitors history, request access »

Allozyne Patents

Allozyne Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014140347-A2 Novel nucleic acid molecules Inactive 15-Mar-2013
WO-2014140347-A3 Novel nucleic acid molecules Inactive 15-Mar-2013
WO-2014044873-A1 Amino acid derivatives Inactive 24-Sep-2012
WO-2014044872-A1 Cell lines Inactive 24-Sep-2012
WO-2012032181-A3 Antibody derivatives Inactive 10-Sep-2010 C07K16/244
To view Allozyne’s complete patent history, request access »

Allozyne Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allozyne Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Accelerator Life Science Partners Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Amgen Ventures Corporate Venture Capital Minority
MPM BioImpact Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Allozyne FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process